Cargando…
Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic
To compare liver cancer resectability rates before and during the COVID-19 pandemic. BACKGROUND: Liver cancers usually present with nonspecific symptoms or are diagnosed through screening programs for at-risk patients, and early detection can improve patient outcomes. In 2020, the COVID-19 pandemic...
Autores principales: | Li, Daniel, Jia, Angela Y., Zorzi, Jane, Griffith, Paige, Kim, Amy K., Dao, Doan, Anders, Robert A., Georgiades, Christos, Liddell, Robert P., Hong, Kelvin, Azad, Nilofer S., Ho, Won Jin, Baretti, Marina, Christenson, Eric, Baghdadi, Azarakhsh, Kamel, Ihab R., Meyer, Jeffrey, Ghabi, Elie, Burkhart, Richard A., Lafaro, Kelly, He, Jin, Shubert, Chris, Yarchoan, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782462/ https://www.ncbi.nlm.nih.gov/pubmed/36590894 http://dx.doi.org/10.1097/AS9.0000000000000207 |
Ejemplares similares
-
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis
por: Gupta, Amol, et al.
Publicado: (2023) -
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic
por: Jia, Angela Y., et al.
Publicado: (2021) -
Current Surgical Management Strategies for Colorectal Cancer Liver Metastases
por: Ivey, Gabriel D., et al.
Publicado: (2022) -
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
por: Chen, Krista Y., et al.
Publicado: (2022) -
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
por: Alden, Stephanie L., et al.
Publicado: (2023)